Targeting the adenosinergic system in restless legs syndrome: A pilot, "proof-of-concept" placebo-controlled TMS-based protocol.
Lanza G, Salemi M, Mogavero MP, Catania V, Galeano A, Garifoli A, Lanuzza B, Morreale M, Tripodi M, Cantone M, Cappellani F, Concerto C, Rodolico A, Pennisi M, Bella R, Ferri R.
Lanza G, et al. Among authors: bella r.
PLoS One. 2024 May 10;19(5):e0302829. doi: 10.1371/journal.pone.0302829. eCollection 2024.
PLoS One. 2024.
PMID: 38728342
Free PMC article.